Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Diego Dr. Dennis A Carson Disease Team Research I Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT) $19,999,826
University of California, San Diego Dr. Gene Wei-Ming Yeo Basic Biology I RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency $1,308,901
University of California, San Diego Karl H. Willert Basic Biology I WNT signaling and the control of cell fate decisions in human pluripotent stem cells. $1,329,298
University of California, Davis Dr. Min Zhao Basic Biology I Directing migration of human stem cells with electric fields $816,228
University of California, Los Angeles Dr. Michael A. Teitell Basic Biology I Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer $1,323,029
University of Southern California Dr. Martin Pera Basic Biology I The stem cell microenvironment in the maintenance of pluripotency and reprogramming $1,325,723
Stanford University Dr. Julien Sage Basic Biology I The retinoblastoma (RB) gene family in cellular reprogramming $1,357,085
Stanford University Dr. Susan K McConnell Basic Biology I Identification and characterization of human ES-derived DA neuronal subtypes $1,404,853
University of California, Los Angeles Bennett G Novitch Basic Biology I Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons $1,228,278
University of California, Los Angeles Dr. Robb Maclellan Dr. Basic Biology I Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate $917,667
University of Southern California Dr. Wange Lu Basic Biology I Defining the molecular mechanisms of somatic cell reprogramming $1,365,580
Stanford University Professor Helen M. Blau PhD Basic Biology I Molecular Mechanisms of Reprogramming towards Pluripotency $1,408,332
University of California, Los Angeles Dr. Luisa Iruela-Arispe Basic Biology I Molecular Characterization and Functional Exploration of Hemogenic Endothelium $1,371,477
City of Hope, Beckman Research Institute Prof. John A. Zaia Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium 2nd Annual Symposium of the CIRM Alpha Stem Cell Clinics Network “Alpha Clinics – Making the Future a Reality for Stem Cell-Based Therapies” $79,287
University of California, San Francisco Ellen B Fung Conference – 2026 SPARK Annual Meeting 2026 CIRM SPARK Annual Meeting $116,994
Capitol Impact Consulting, LLC Alexis Carlsson Conference – 2026 SPARK Annual Meeting Bright Minds Symposium: 2026 SPARK Annual Meeting $118,000
Generation STEAM Silvana DelPiccolo Conference – 2026 SPARK Annual Meeting Manage the 2025 Annual SPARK Conference $114,000
The Regents of the University of California on behalf of its Riverside Campus Dr. Huinan Hannah Liu Conference – 2026 SPARK Annual Meeting Manage the 2024 SPARK Annual Meeting $110,000
Cedars-Sinai Medical Center Cedars-Sinai Medical Center Wafa Tawackoli Conference – 2026 SPARK Annual Meeting 2023 CIRM SPARK Research Conference $100,000
UCSF Benioff Children’s Hospital Oakland Ellen B Fung Conference – 2026 SPARK Annual Meeting 2022 CIRM SPARK Research Conference $79,336
University of California, Davis Gerhard Gerhard Bauer Conference – 2026 SPARK Annual Meeting The 2020 SPARK Annual Meeting $22,876
Pathways to Stem Cell Science Dr. Victoria Fox Conference – 2026 SPARK Annual Meeting 2019 SPARK Annual Meeting $49,915
University of California, Davis Gerhard Gerhard Bauer Conference – 2026 SPARK Annual Meeting The 2018 SPARK Annual Meeting $39,391
City of Hope, Beckman Research Institute Dr. Paul M. Salvaterra Conference – 2026 SPARK Annual Meeting Manage the 2017 SPARK Annual Meeting $22,555
California State University San Marcos Corporation James Jancovich Conference – Manage The Bridges Annual Meeting The 2022 Bridges Annual Meeting $137,297
California State University San Marcos Corporation Dr. Bianca Romina Mothé Conference – Manage The Bridges Annual Meeting 2020 and 2021 Bridges Annual Meeting $125,180
California State University San Marcos Corporation Dr. Bianca Romina Mothé Conference – Manage The Bridges Annual Meeting 2018 and 2019 Bridges Annual Meeting $291,622
San Diego State University Foundation Ralph Feuer Conference – Manage The Bridges Annual Meeting 2017 Bridges Annual Meeting $153,449
University of California, Los Angeles Dr. Brigitte Gomperts Conference – Lung Regenerative Medicine Workshop Stem Cells for Lung Diseases – Overcoming Barriers to Find New Therapies $44,548
IQVIA, Inc. Dr. Amritha Jaishankar Translating Center A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients $15,000,000
IQVIA, Inc. Peter Robinson Accelerating Center An Accelerating Center designed to expedite the development and delivery of high quality stem cell therapies to patients $11,772,453
University of California, San Diego Dr. Catriona Jamieson Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium UCSD Division of Regenerative Medicine and CIRM Alpha Clinics Network Symposium $37,778
Mosaic Event Management, Inc. Ron Johnson Conference – Manage The 2016 Bridges And SPARK Annual Meetings 2016 CIRM Bridges & SPARK Meetings $205,388
University of California, Irvine Dr. Aileen J Anderson Quest – Discovery Stage Research Projects Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling $2,250,144
Children’s Hospital of Los Angeles Dr Biraj Mahato Quest – Discovery Stage Research Projects Chemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness. $1,711,000
University of California, San Francisco Claire Clelland Quest – Discovery Stage Research Projects Developing a universal CRISPR gene therapy approach to treat C9orf72 ALS $2,740,592
University of California, Los Angeles Dr. Koki Morizono Quest – Discovery Stage Research Projects B cell receptor-mediated lentiviral expression of anti-HIV antibody $2,751,504
University of California, San Francisco Faranak Fattahi Quest – Discovery Stage Research Projects Drug discovery for Charcot Marie Tooth Disease using hPSC-derived Schwann cells $2,471,664
City of Hope, Beckman Research Institute Dr. Christine E. Brown Quest – Discovery Stage Research Projects Development of a Trifunctional Self-Renewing Memory CAR T Cell Therapy to Overcome the Heterogeneity and Suppressive Microenvironment of Glioblastoma $2,700,810
University of California, San Diego Dr. Neil Carson Chi Quest – Discovery Stage Research Projects Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies $2,772,000
University of California, San Francisco Dr. Qizhi Tang PhD Quest – Discovery Stage Research Projects Genome editing of human Tregs to enable combinational tolerogenic therapy with T cell-targeted biologics for T1D $2,485,549
Palo Alto Veterans Institute for Research Dr. Jian Luo Quest – Discovery Stage Research Projects Human induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury $2,255,189
Palo Alto Veterans Institute for Research Irene Lorenzo Llorente Quest – Discovery Stage Research Projects Inhibitory interneurons derived from human induced pluripotent stem cells to treat stroke $2,140,122
Savanna Biotherapeutics, Inc. Dr. Sunil Gandhi Ph.D Quest – Discovery Stage Research Projects Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) $1,413,387
University of California, San Francisco Faranak Fattahi Quest – Discovery Stage Research Projects Drug discovery for gastrointestinal motility disorders using hPSC-derived enteric ganglioids $1,954,367
University of Southern California Dr. Justin K Ichida Quest – Discovery Stage Research Projects Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS $2,072,560
Cedars-Sinai Medical Center Dr. Ritchie Ho Quest – Discovery Stage Research Projects C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy $2,274,768
University of California, Davis Ricardo Anibal Maselli MD Quest – Discovery Stage Research Projects Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy $1,500,000
Adverum Biotechnologies Inc. Cameron Keast Baker Quest – Discovery Stage Research Projects Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin $1,053,471
Stanford University Dr. Robert Negrin MD Quest – Discovery Stage Research Projects Orthogonal IL2 Receptor Transduced Regulatory T Cells for Clinical Application $1,920,652
1 2 3 4 5 6 7 8 9 10 11 … 32

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More